Tapentadol is partly metabolized through the hepatic enzymes CYP2C9, CYP2C19, and CYP2D6 so it innately has interactions with prescription drugs that boost or repress the action/expression of a number of of such enzymes, in addition to with substrates of those enzymes (as a consequence of Opposition for that enzyme); some enzyme mediators/substrate